Report cover image

Biologics Contract Manufacturing Market - 2024-2033

Publisher DataM Intelligence 4Market Research LLP
Published Jan 22, 2026
Length 207 Pages
SKU # DTAM21124365

Description

Biologics Contract Manufacturing Market Overview:
The Biologics Contract Manufacturing Market was valued at US$ 26.03 billion in 2024 and is anticipated to reach US$ 83.47 billion by 2033, at a CAGR of 0.14 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Biologics Contract Manufacturing Market.

This report delivers a comprehensive overview of the Biologics Contract Manufacturing Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Biologics Contract Manufacturing Market. The Biologics Contract Manufacturing Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

Biologics Contract Manufacturing Market Scope:
Key Players
• Wuxi Biologics
• AGC Biologics
• Lonza
• FUJIFILM Diosynth Biotechnologies.
• Thermo Fisher Scientific Inc.
• KBI Biopharma
• Vetter Pharma
• Recipharm AB.
• Abzena Ltd
• Samsung Biologics
• Eurofins CDMO
• Catalent
• Boehringer Ingelheim International GmbH.THE LIST IS NOT EXHAUSTIVE

Major Highlights
This report delivers a comprehensive overview of the Biologics Contract Manufacturing Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Biologics Contract Manufacturing Market. The Biologics Contract Manufacturing Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

207 Pages
1. Market Introduction and Scope
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. Executive Insights and Key Takeaways
3. Market Highlights and Strategic Takeaways
3.1. Key Trends and Future Projections
4. Snippet by Product Type
4.1. Snippet by Platform
4.2. Snippet by Application
5. Snippet by Region
6. Dynamics
6.1. Impacting Factors
6.1.1. Drivers
6.1.1.1. Rising Demand for Biologics and Expansion of CDMO Facilities
7. Growth of Biosimilars
8. Restraints
8.1. High Capital and Operations Cost
9. Opportunities
9.1. Strategic Partnerships between Pharma/Biotech and CDMOs
9.1.1. Impact Analysis
10. Strategic Insights and Industry Outlook
10.1. Market Leaders and Pioneers
10.2. Latest Developments and Breakthroughs
10.3. Regulatory and Reimbursement Landscape
10.4. Porter’s Five Forces Analysis
10.5. SWOT Analysis
10.6. Unmet Needs and Gaps
10.7. Recommended Strategies for Market Entry and Expansion
10.8. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
10.9. Key Opinion Leaders
11. Global Biologics Contract Manufacturing Market, By Product Type
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.1.2. Market Attractiveness Index, By Product Type
11.2. Monoclonal Antibodies*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Recombinant Proteins
11.4. Cell and Gene Therapies
11.5. Vaccines
11.6. Others
12. Global Biologics Contract Manufacturing Market, By Platform
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Platform
12.1.2. Market Attractiveness Index, By Platform
12.2. Mammalian*
12.2.1. Introduction
12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. Microbial
12.4. Others
13. Global Biologics Contract Manufacturing Market, By Application
13.1. Introduction
13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.1.2. Market Attractiveness Index, By Application
13.2. Oncology*
13.2.1. Introduction
13.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
13.3. Metabolic Diseases
13.4. Autoimmune Diseases
13.5. Ophthalmology
13.6. Infectious Diseases
13.7. Cardiovascular Diseases
13.8. Others
14. Global Biologics Contract Manufacturing Market, By Region
14.1. Introduction
14.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
14.1.2. Market Attractiveness Index, By Region
14.2. North America
14.2.1. Introduction
14.2.2. Key Region-Specific Dynamics
14.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Platform
14.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
14.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
14.2.6.1. U.S.
14.2.6.2. Canada
14.2.6.3. Mexico
14.3. Europe
14.3.1. Introduction
14.3.2. Key Region-Specific Dynamics
14.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Platform
14.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
14.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
14.3.6.1. Germany
14.3.6.2. U.K.
14.3.6.3. France
14.3.6.4. Spain
14.3.6.5. Italy
14.3.6.6. Rest of Europe
14.4. South America
14.4.1. Introduction
14.4.2. Key Region-Specific Dynamics
14.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Platform
14.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
14.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
14.4.6.1. Brazil
14.4.6.2. Argentina
14.4.6.3. Rest of South America
14.5. Asia-Pacific
14.5.1. Introduction
14.5.2. Key Region-Specific Dynamics
14.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Platform
14.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
14.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
14.5.6.1. China
14.5.6.2. India
14.5.6.3. Japan
14.5.6.4. South Korea
14.5.6.5. Rest of Asia-Pacific
14.6. Middle East and Africa
14.6.1. Introduction
14.6.2. Key Region-Specific Dynamics
14.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Platform
14.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
15. Competitive Landscape and Market Positioning
15.1. Competitive Overview and Key Market Players
15.2. Market Share Analysis and Positioning Matrix
15.3. Strategic Partnerships, Mergers & Acquisitions
15.4. Key Developments in Product Portfolios and Innovations
15.5. Company Benchmarking
16. Company Profiles
16.1. Wuxi Biologics*
16.1.1. Company Overview
16.1.2. Product Portfolio
16.1.3. Financial Overview
16.1.4. Key Developments
16.1.5. SWOT Analysis
16.2. AGC Biologics
16.3. Lonza
16.4. FUJIFILM Diosynth Biotechnologies.
16.5. Thermo Fisher Scientific Inc.
16.6. KBI Biopharma
16.7. Vetter Pharma
16.8. Recipharm AB.
16.9. Abzena Ltd
16.10. Samsung Biologics
16.11. Eurofins CDMO
16.12. Catalent
16.13. Boehringer Ingelheim International GmbH.THE LIST IS NOT EXHAUSTIVE
17. Appendix
17.1. About Us and Services
17.2. Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us